Wednesday, November 3, 2021

Cipla unit gets notice from US firm for termination of acquisition deal

Cipla unit gets notice from US firm for termination of acquisition deal In November 2018, Cipla had announced that InvaGen Pharmaceuticals Inc has entered into definitive agreements to acquire US-based speciality business firm Avenue Therapeutics for up to USD 215 million (around Rs 1,560 crore).

from Moneycontrol Business News https://ift.tt/3BMCi0g
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Bitcoin stays near $64K, Ethereum underperforms as weak risk appetite keeps crypto markets under pressure

Bitcoin traded near $64,000 and Ethereum underperformed as risk appetite weakened. The global crypto market capitalization edged down 2% to ...